The pioneer in cardiac health takes a huge step in making early
detection and diagnosis more accessible to consumers worldwide
ST.
JOHN'S, NL, June 20,
2024 /PRNewswire-PRWeb/ -- Sparrow BioAcoustics
[Sparrow], a pioneer in the field of bioacoustic AI technology and
maker of Stethophone, announces the launch of the world's first
Cardiac AI for consumers, now approved for use in Ukraine.
"Stethophone embodies our commitment to
provide everyone everywhere with the power, agency and access to
fight heart disease right in their own hands."
Stethophone® V3 is the world's first AI-powered medical
stethoscope that runs on your smartphone, designed for both
consumers and medical professionals. A groundbreaking advancement
in personalized heart health, this innovative software application
turns smartphones into medical-grade stethoscopes, allowing people
to capture, analyze, and share critical heart health data with
medical personnel anywhere.
Stethophone works by harnessing the built-in microphone of a
smartphone to capture the nuanced sounds of the heart. Through
sophisticated bioacoustics engineering, these sounds are then
filtered to provide clear, medical-grade diagnostic signals. The
recently approved release in Ukraine further interprets these sounds using
Sparrow's proprietary AI to identify common rhythmic and structural
anomalies of the heart.
This historic innovation means that detecting or ruling out
numerous conditions can happen faster and be more accessible, for
millions of people, with only a download. Citizens of Ukraine who are now living without reliable,
in-person access to their primary care doctors or cardiac
specialists can now share real cardiac medical data collected at
home. With the assistance of the AI, doctors can more easily
identify cardiac symptoms and make faster recommendations to seek
specialized care or further testing.
Sparrow was the first company to redefine how diagnostically
rich chest sounds could be captured, augmented and visualized, and
the first to receive FDA clearance as a class II medical device for
a smart-phone based stethoscope for consumer use. Sparrow will be
giving North American audiences a first look at the new cardiac AI
approved for use in Ukraine at
Collision Conference in Toronto,
Canada between June 17 and June
20. The team will be conducting live, hands on demos for
thousands of attendees of the show.
"We are at the forefront of a revolution in personalized heart
health," said Mark Attila Opauzsky, CEO of Sparrow BioAcoustics.
"Stethophone embodies our commitment to provide everyone everywhere
with the power, agency and access to fight heart disease right in
their own hands. We are deeply privileged to have a chance to apply
our work to first help the millions of people displaced by war in
Ukraine who are symptomatic or
concerned about their heart health." Stethophone cardiac AI is
currently only available in Ukraine through the Ukraine Apple AppStore and
is not cleared for use in USA or Canada. To learn more about Stethophone and
Sparrow BioAcoustics, please visit https://stethophone.com/.
About Sparrow BioAcoustics
Sparrow BioAcoustics, with offices in Newfoundland, Nova
Scotia and Toronto, Canada,
is leading the Software as a Medical Device industry in new
directions for cardiac and pulmonary disease detection. Our team of
physicians, engineers and data scientists are working to unlock the
richest source of diagnostic information about cardiac and
pulmonary conditions. Our mission is to help the millions of people
at-risk and suffering from cardiac and respiratory disease to live
longer, healthier lives enabled by earlier detection and quicker
treatment.
Media Contact
Elle Woulfe, Sparrow
Bioacoustics, 1 6172567185, elle.woulfe@gmail.com,
https://stethophone.com/
View original content to download
multimedia:https://www.prweb.com/releases/sparrow-bioacoustics-maker-of-the-groundbreaking-stethophone-launches-first-ai-for-consumers-focused-on-cardiac-diseases-302177096.html
SOURCE Sparrow Bioacoustics